Skip to main content

Table 5 Age stratification in the incidence of synchronous peritoneal metastases according to the primary origin in the Czech population between 2014 and 2016

From: Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study

 

Age by diagnosis

p rate

0–49 years

50–59 years

60–69 years

70–79 years

80 years and above

Peritoneal carcinomatosis total

207 (6.6%)

429 (13.7%)

1048 (33.4%)

894 (28.5%)

559 (17.8%)

< 0.001

 Malignant neoplasm of the colon and rectum (C18–C20)

56 (6.5%)

103 (12.0%)

262 (30.4%)

257 (29.8%)

183 (21.3%)

< 0.001

 Malignant neoplasm of the ovary (C56)

26 (5.3%)

70 (14.3%)

157 (32.1%)

136 (27.8%)

100 (20.4%)

< 0.001

 Malignant neoplasm of the stomach (C16)

41 (10.0%)

70 (17.2%)

135 (33.1%)

101 (24.8%)

61 (15.0%)

< 0.001

 Malignant neoplasm of the pancreas (C25)

16 (4.2%)

52 (13.7%)

144 (38.0%)

112 (29.6%)

55 (14.5%)

< 0.001

 Malignant neoplasm of the trachea, bronchus, and lung (C33, C34)

9 (5.1%)

24 (13.6%)

73 (41.2%)

49 (27.7%)

22 (12.4%)

< 0.001

 Malignant neoplasm of the gallbladder and biliary tract (C23, C24)

4 (2.4%)

20 (12.0%)

53 (31.7%)

49 (29.3%)

41 (24.6%)

< 0.001

 Malignant neoplasm of the liver and intrahepatic bile ducts (C22)

4 (3.2%)

11 (8.9%)

38 (30.6%)

52 (41.9%)

19 (15.3%)

< 0.001

 Malignant neoplasm of the uterus (C54, C55)

4 (3.4%)

13 (11.2%)

44 (37.9%)

36 (31.0%)

19 (16.4%)

< 0.001

 Other locality of the primary tumor

47 (11.3%)

66 (15.9%)

142 (34.1%)

102 (24.5%)

59 (14.2%)

< 0.001